An observational study in Prostate Cancer and Hyperplasia, sponsored by Ziv Hospital. Status unknown at 1 site in Israel. Open to male participants aged 60 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2007-09-05.
Sponsored by Ziv Hospital · Observational
Early detection of prostrate cancer and development of metastases. The research will attempt to match the SCM test (structuredness of the cytoplasmic matrix) in lymphocytes as an early cancer detection test using Florescent Activated Cell Sorting (FACS) as a replacement for the CellScan instrument. The test is based on measurement of cellular changes in response to the specific prostate antigen, PSA.
6,367 studies on the registry are indexed under Prostatic Neoplasms; 1,397 are open to participants now.
This study's planned enrollment of 40 is below the median of 200 across 1,179 observational studies indexed under Prostatic Neoplasms.
Browse Prostatic Neoplasms studies →Ziv Hospital is the lead sponsor of 82 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Experimental group : Males between the ages of 60-90 years, with medical diagnosis of prostate cancer according to both clinical and hematological examinations, before receiving any medical treatment.
Control Group 1: Males between the ages of 60-90 years, with diagnosed benign prostate hyperplasia -BPH.
Control Group 2: Males between the ages of 60-90 years, medically diagnosed as healthy.
Control Group 3: Males between the ages of 60-90 years, medically diagnosed with another form of cancer, not prostate.
Exclusion Criteria:
Experimental group: Other known cancer or systemic infection. Control Group 1: Other known cancer or systemic infection. Control Group 2:Past hematological disorders nor cancer growth history. other known systemic infection, nor urinary tract infection. Patients hospitalized for orthopedic injuries of any type who are otherwise free of urinary tract infections.
Control Group 3:Other known systemic infection, nor urinary tract infection.
-
10 diagnosed men in age 60 - 90 with Prostate Cancer
10 patients with benign growth
10 health volunteers
10 patients diagnosed with other cancer
This study is status unknown, as verified in Aug 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ziv Hospital